GASTRIC-ESOPHAGEAL CANCER

Clinical trials for GASTRIC-ESOPHAGEAL CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTRIC-ESOPHAGEAL CANCER trials appear

Sign up with your email to follow new studies for GASTRIC-ESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for hard-to-treat cancers? first human trial launches

Disease control Recruiting now

This early-stage study tests a new drug called azirkitug, alone or with other medicines, in people with advanced solid tumors like lung, head/neck, and other cancers. The goal is to find safe doses and check side effects. About 694 adults will take part at sites worldwide.

Matched conditions: GASTRIC-ESOPHAGEAL CANCER

Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control

Last updated May 14, 2026 12:01 UTC

GASTRIC-ESOPHAGEAL CANCER

Get alerted when new GASTRIC-ESOPHAGEAL CANCER trials appear

New hope for hard-to-treat cancers? first human trial launches